Preclinical safety evaluation of the adrenomedullin-binding antibody Adrecizumab in rodents, dogs and non-human primates

There is no fulltext present in this item.

Title:	Preclinical safety evaluation of the adrenomedullin-binding antibody Adrecizumab in rodents, dogs and non-human primates
Author(s):	Geven, C.B.C.A.G.; Kox, M. ; Blet, A.; Mebazaa, Alexandre; Schroedter, Mathias; Struck, Joachim; Bergmann, A.; Pickkers, P.
Publication year:	2019
Source:	Toxicology and Applied Pharmacology, vol. 369, (2019), pp. 1-16
ISSN:	0041-008X
DOI:	https://doi.org/10.1016/j.taap.2019.02.014
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : http://hdl.handle.net/2066/202597
Display more details
Subject:	All institutes and research themes of the Radboud University Medical Center Radboudumc 4: lnfectious Diseases and Global Health RIMLS: Radboud Institute for Molecular Life Sciences
Organization:	Intensive Care
Journal title:	Toxicology and Applied Pharmacology
Volume:	vol. 369
Page start:	p. 1
Page end:	p. 16